US › Healthcare

Regencell Bioscience Holdings Ltd (RGC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$6.05-1.31%
Last close · 2026-08-04

Key statistics

Market cap
$2.79B
Forward P/E
0.0
P/B
2,506.14
Book value
$0.00
EPS (TTM)
$-0.01
52-week high
$69.00
52-week low
$4.51
50-day MA
$12.70
200-day MA
$21.12
Beta
1.83

Shareholding

Insiders
88.38%
Institutions
0.14%

Largest institutional holders

FundStake
Geode Capital Management, LLC0.08%
Marex Group Ltd0.01%
GSA Capital Partners LLP0.01%
Vident Advisory, LLC0.01%
Squarepoint Ops LLC0.01%
UBS Group AG0.00%
Morgan Stanley - Brokerage Accounts0.00%
Bank of America Corp0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Regencell Bioscience Holdings Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.